Toggle navigation image image
Toggle navigation logologo
image image
  • About Inflarx
    • Leadership Team
    • Board
    • Company History
    • Vision
  • R&D
    • About Complement
    • About C5A
    • Technology
    • Pipeline
    • Clinical Development
      • Hidradenitis Suppurativa
        • Shine Study FAQ
      • ANCA-Associated Vasculitis
      • Pyoderma Gangraenosum
      • COVID-19
      • cSCC
    • Clinical Trials
    • Publications & Posters
  • Investors
    • Press Releases
    • Events & Presentations
    • Financial Information
    • Share Information
    • Analyst Coverage
    • Corporate Governance
    • Annual/Extraordinary General Meetings
    • E-mail alerts
  • Career
    • Open Positions

Financial-Information

  • Home
  • Investors
  • Financial Information

Financial-Information InflaRx SEC filings and financial reports

The following list represents all InflaRx SEC filings and financial reports. 

Annual Reports

InflaRx PFIC Annual Information Statement 2021

InflaRx PFIC Annual Information Statement 2020

InflaRx PFIC Annual Information Statement 2019

InflaRx PFIC Annual Information Statement 2018

DateFiling TypeFiling DescriptionDownload / View
2022-12-21 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-11-09 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-11-09 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-09-29 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-09-08 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-08-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-07-26 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-07-06 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-06-29 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-05-12 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-04-28 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-04-07 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-03-31 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-03-24 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-03-24 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022-03-17 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-03-08 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-02-28 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-02-16 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-02-14 SC 13G/A Statement of acquisition of beneficial ownership by individuals
2022-02-03 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-01-10 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2022-01-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]





 

 image
Quick Links
  • Impressum
  • Privacy
  • Technology
  • News
  • Career
  • Disclaimer
  • Contact
  • Newsletter
  • Member area
Contact Jena

InflaRx N.V.
Winzerlaer Str. 2
07745 Jena

+49 (0)3641 508 180

info@inflarx.de

InflaRx on Linkedin

Contact Munich

InflaRx N.V.
Fraunhoferstraße 22
82152 Martinsried

+49 (0)89 414 189 78 00

info@inflarx.de

© Copyright 2017 All Rights Reserved.
  • Developed by Ementals